← SynDRA
LURASIDONE
SynDRA canonical compound SYN0024406 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | HTR7 |
|---|
| Mechanism of action | Serotonin receptor antagonist |
|---|
| Indication | schizophrenia |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- DRD2
- HTR2A
- ADRA2A
- ADRA2C
- HTR1A
- HTR7
- Drd2
- Htr1a
- Htr2a
Mechanisms of action (all sources)
- Dopamine receptor antagonist
- Serotonin receptor antagonist
- HTR2A ANTAGONIST
- Serotonin 2a (5-HT2a) receptor antagonist
- DRD2 ANTAGONIST
- Dopamine D2 receptor antagonist
- HTR2A MODULATOR
- DRD2 MODULATOR
Drug classes
- Atypical Antipsychotic
- Adrenergic Agents
- Adrenergic alpha-2 Receptor Antagonists
- Adrenergic alpha-Antagonists
- Adrenergic Antagonists
- Antipsychotic Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Dopamine Agents
- Dopamine Antagonists
- Dopamine D2 Receptor Antagonists
- Neurotransmitter Agents
ATC classes
Cross-references
Synonyms
- SM-13496
- latuda
- lurasidone hydrochloride
- lurasidone HCl
- Lurasidona
- SM-13496 FREE BASE
- Lurasidone hydrochloride
- Lurasidone HCl
- Lurasidone hydrochloride (USAN)
- MK-3756
- SMP-13496
- N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide
- Lurasidone [INN]
- (3aR,4S,7R,7aS)-2-((1R,2R)-2-(4-(1,2-Benzothiazol-3-yl)piperazin-1-ylmethyl)cyclohexylmethyl)hexahydro-4,7-methano-2H-isoindole-1,3-dione
- CHEBI:70735
- 22IC88528T
- SM13496
- (3aR,4S,7R,7aS)-2-{[(1R,2R)-2-{[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl}cyclohexyl]methyl}hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
- lurasidona
- lurasidonum
- UNII-22IC88528T
- HSDB 8228
- (3aR,4S,7R,7aS)-2-{(1R,2R)-2-(4-(1,2-Benzisothiazol-3-yl)piperazin-1-ylmethyl)cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione
- (3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione
- SM13,496
- LURASIDONE [MI]
- SM-13,496
- LURASIDONE [VANDF]
- LURASIDONE [WHO-DD]
- SCHEMBL677525
- GTPL7461
- CHEMBL1237021
- BDBM85222
- DTXSID40870340
- EX-A504
- HMS3886A20
- AMY32530
- ZINC3927822
Reported adverse events
- TIA
- GH
- Dizziness
- Fatigue
- Akathisia
- Anxiety
- Dysphagia
- Dystonia
- Insomnia
- Nausea
- Parkinsonism
- Somnolence
Look up LURASIDONE in the interactive SynDRA portal →